top of page
All Articles
Search


Purdue Pharma and Karma
Is $5.5 billion justice—or just closure without accountability?
In this powerful and deeply personal reflection, Rob Kent, Esq., President of Kent Strategic Advisors and former New York State drug policy official, examines the conclusion of the federal criminal case against Purdue Pharma. For policymakers, clinicians, and those impacted by the opioid crisis, Kent’s message is clear: financial penalties alone are not enough.
Robert Kent
May 23 min read


The Intersection Between Pain and Opioid Addiction
Robert Kent, Esq., writes that in trying to fix the opioid crisis with policy changes, we may have created a second one.
Robert Kent
Apr 253 min read
bottom of page

